p21-Activated Kinases as Promising Therapeutic Targets in Hematological Malignancies

The authors review the most recent studies that provide experimental evidence showing how specific p21-activated kinases regulate the properties of leukemic stem cells and drug-resistant cells to initiate and maintain hematological malignancies.